专题:Lipoproteins and Cardiovascular Health

This cluster of papers focuses on the efficacy and safety of cholesterol-lowering treatments, particularly statins, in the prevention and management of cardiovascular diseases. It includes meta-analyses, clinical trials, guidelines, and genetic studies related to LDL cholesterol, atherosclerotic cardiovascular risk, hypercholesterolemia, and the role of C-reactive protein. The cluster also explores the impact of statins on various patient populations and their pleiotropic effects.
最新文献
Relationship Between Neutrophil Count and 90‐Day Outcomes and Effect of Dual Antiplatelet Therapy in Patients With Acute Ischemic Stroke or Transient Ischemic Attack: A Post Hoc Analysis of the INSPIRES Trial

article Full Text OpenAlex

Rationale for the Routine Screening of Lipoprotein (a) in Cardiovascular Risk Assessment

article Full Text OpenAlex

High Density Lipoprotein Particle Composition, Functionality, Deficiency, and Atherosclerotic Cardiovascular Disease Risk: A Review

review Full Text OpenAlex

Ticagrelor Monotherapy vs. Ticagrelor With Aspirin in Bleeding and Cardiovascular Events in Acute Coronary Syndrome Patients According to Renal Function: The Subanalysis From the TICO Trial

article Full Text OpenAlex

Comment on: Hard-flaccid syndrome: a report of two cases

article Full Text OpenAlex

The 2025 Guideline Update Endorses Ticagrelor Monotherapy After ≥1 Month of DAPT Post-PCI in Patients With ACS

article Full Text OpenAlex

Maturation of Lipid Management in the 2025 ACC/AHA Acute Coronary Syndrome Guideline

article Full Text OpenAlex

Statin-induced risk of diabetes does not reduce cardiovascular benefits in primary prevention: a 6-year propensity-score matched study in a large population

article Full Text OpenAlex

Prevalence and Correlates of Lipoprotein(a) Testing in a Diverse Cohort of U.S. Adults

article Full Text OpenAlex

Impact of In-Hospital PCSK9 Inhibition on Myocardial Inflammation After Myocardial Infarction

article Full Text OpenAlex

近5年高被引文献
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

article Full Text OpenAlex 4530 FWCI686.397

SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe

article Full Text OpenAlex 1031 FWCI153.074

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

article Full Text OpenAlex 750 FWCI217.63

2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults

article Full Text OpenAlex 664 FWCI136.106

Global epidemiology of dyslipidaemias

review Full Text OpenAlex 603 FWCI33.572

Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

article Full Text OpenAlex 570 FWCI290.136

Pathophysiology of Atherosclerosis

review Full Text OpenAlex 565 FWCI22.233

Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association

review Full Text OpenAlex 506 FWCI28.465

Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction

article Full Text OpenAlex 372 FWCI107.632

Stroke genetics informs drug discovery and risk prediction across ancestries

review Full Text OpenAlex 368 FWCI19.933